NCT03688022View on ClinicalTrials.gov

Relative Bioavailability and Drug-drug Interaction Study With MT-7117 and a Proton Pump Inhibitor

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 25, 2018

Primary Completion Date

December 22, 2018

Study Completion Date

December 22, 2018

Conditions
Healthy Volunteer
Interventions
DRUG

MT-7117

MT-7117

DRUG

PPI

Proton pump inhibitor

DIETARY_SUPPLEMENT

Acidic beverage

Acidic beverage

Trial Locations (1)

Unknown

Investigational Centre(s), Germany

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma America Inc.

INDUSTRY